Reversion
Reversion, licence 80114082: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- PalCare Enterprises Inc
- NPN or DIN-HM
- 80114082
- Status
- Active licence
- Licence date
- 9 November 2021
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Vaginale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide hyaluronique, sel de sodium Source : Streptococcus equi - capsule extracellulaire bactérienne | 5.0 mg | Not calculated |
Non-medicinal ingredients
Gomme arabique (acacia), Amidon topique, Alun de sodium, Extrait de fruits de Terminalia chebula, Extrait de feuilles de Prunella vulgaris, Extrait de fruits de Phyllanthus Emblica, Bioflavonoïdes, Extrait d'hamamélis, Gomme arabique, Extrait du fruit de Quercus infectoria, Huile de graine de Punica Granatum
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Femmes | minimum: 18.0 ans | 1.0 Gel | 1.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps promote healing of the vaginal mucosa in menopausal women.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80114082
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.